- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x RX8: 1-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol(Non-covalent)
RX8.4: 15 residues within 4Å:- Chain A: T.510, D.533, L.535, G.562, I.563, T.564
- Chain B: Y.242, F.327, F.329, Q.332, V.333, Y.334, V.359, F.386
- Ligands: SO4.13
12 PLIP interactions:5 interactions with chain A, 7 interactions with chain B- Hydrophobic interactions: A:T.510, B:F.327, B:F.329, B:F.386
- Hydrogen bonds: A:D.533, A:T.564, A:T.564
- Water bridges: A:D.533, B:N.243
- pi-Stacking: B:Y.334, B:F.386, B:F.386
RX8.29: 12 residues within 4Å:- Chain A: F.327, F.329, V.333, Y.334, V.359, F.386
- Chain B: T.510, D.533, L.535, G.562, I.563, T.564
13 PLIP interactions:3 interactions with chain B, 10 interactions with chain A- Hydrophobic interactions: B:T.510, A:F.327, A:F.329, A:F.329, A:V.359, A:F.386, A:F.386
- Hydrogen bonds: B:D.533, B:T.564
- Water bridges: A:N.243
- pi-Stacking: A:Y.334, A:F.386, A:F.386
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 7 residues within 4Å:- Chain A: S.468, C.469, S.479, K.480, N.501, Y.524, D.526
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:Y.524
- Hydrogen bonds: A:C.469, A:S.479, A:N.501, A:D.526
- Water bridges: A:S.407, A:S.407, A:S.468, A:S.468
NAG.6: 5 residues within 4Å:- Chain A: I.26, N.47, V.70, E.71, S.109
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.26
- Hydrogen bonds: A:N.47, A:S.109, A:S.109
NAG.7: 6 residues within 4Å:- Chain A: S.537, M.566, N.568, K.571, T.590, S.591
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.537, A:S.537
- Water bridges: A:R.592
NAG.8: 4 residues within 4Å:- Chain A: R.674, R.695, N.698, R.701
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:R.674
- Hydrogen bonds: A:R.695, A:N.698, A:R.701
NAG.9: 6 residues within 4Å:- Chain A: N.391, S.393, K.396, Q.492, H.493
- Ligands: SO4.14
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.391, A:K.396, A:K.396, A:Q.492
NAG.10: 2 residues within 4Å:- Chain A: N.512, S.514
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.512, A:S.514
NAG.11: 4 residues within 4Å:- Chain A: K.306, G.309, D.310, N.339
No protein-ligand interaction detected (PLIP)NAG.30: 7 residues within 4Å:- Chain B: S.468, C.469, S.479, K.480, N.501, Y.524, D.526
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:Y.524
- Hydrogen bonds: B:C.469, B:S.479, B:D.526, B:D.526
NAG.31: 4 residues within 4Å:- Chain B: S.537, M.566, N.568, S.591
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.537, B:S.537, B:N.568
NAG.32: 2 residues within 4Å:- Chain B: N.512, S.514
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.512, B:S.514
NAG.33: 5 residues within 4Å:- Chain B: N.391, S.393, K.396, Q.492, H.493
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:N.391, B:S.393, B:K.396, B:K.396, B:Q.492
NAG.34: 3 residues within 4Å:- Chain B: G.309, D.310, N.339
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.339
- 28 x SO4: SULFATE ION(Non-functional Binders)
SO4.12: 1 residues within 4Å:- Chain A: R.286
Ligand excluded by PLIPSO4.13: 5 residues within 4Å:- Chain A: T.510, L.535, H.536
- Chain B: Y.334
- Ligands: RX8.4
Ligand excluded by PLIPSO4.14: 5 residues within 4Å:- Chain A: K.364, S.365, N.391, M.394
- Ligands: NAG.9
Ligand excluded by PLIPSO4.15: 4 residues within 4Å:- Chain A: H.536, S.537, T.538, M.566
Ligand excluded by PLIPSO4.16: 3 residues within 4Å:- Chain A: I.41, P.42, T.43
Ligand excluded by PLIPSO4.17: 4 residues within 4Å:- Chain A: R.762, V.793
- Chain B: R.762
- Ligands: SO4.35
Ligand excluded by PLIPSO4.18: 5 residues within 4Å:- Chain A: K.396, Q.397, F.398, K.399, R.400
Ligand excluded by PLIPSO4.19: 3 residues within 4Å:- Chain A: G.39, G.40, R.65
Ligand excluded by PLIPSO4.20: 9 residues within 4Å:- Chain A: C.161, Y.162, D.191, N.192, N.193, N.212, N.213, M.214, Y.446
Ligand excluded by PLIPSO4.21: 5 residues within 4Å:- Chain A: R.354, V.403, D.405, V.437, Y.470
Ligand excluded by PLIPSO4.22: 2 residues within 4Å:- Chain A: N.705, Y.729
Ligand excluded by PLIPSO4.23: 3 residues within 4Å:- Chain A: K.471, Y.472, R.523
Ligand excluded by PLIPSO4.24: 4 residues within 4Å:- Chain A: R.714, K.736, R.762
- Chain B: R.762
Ligand excluded by PLIPSO4.25: 6 residues within 4Å:- Chain A: S.85, K.86, S.87
- Chain B: S.641, F.642, K.666
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain A: Q.474, K.498, E.521
Ligand excluded by PLIPSO4.27: 1 residues within 4Å:- Chain A: R.728
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain A: K.185, V.186, T.206, E.207
Ligand excluded by PLIPSO4.35: 3 residues within 4Å:- Chain B: R.714, K.736
- Ligands: SO4.17
Ligand excluded by PLIPSO4.36: 2 residues within 4Å:- Chain B: R.286, K.289
Ligand excluded by PLIPSO4.37: 4 residues within 4Å:- Chain B: L.535, H.536, S.537, T.538
Ligand excluded by PLIPSO4.38: 6 residues within 4Å:- Chain A: S.641, F.642, K.666
- Chain B: S.85, K.86, S.87
Ligand excluded by PLIPSO4.39: 3 residues within 4Å:- Chain B: Q.474, K.498, E.521
Ligand excluded by PLIPSO4.40: 5 residues within 4Å:- Chain B: K.396, Q.397, F.398, K.399, R.400
Ligand excluded by PLIPSO4.41: 3 residues within 4Å:- Chain B: K.471, Y.472, R.523
Ligand excluded by PLIPSO4.42: 9 residues within 4Å:- Chain B: P.60, F.63, H.64, R.99, S.100, F.101, S.102, G.103, L.104
Ligand excluded by PLIPSO4.43: 4 residues within 4Å:- Chain B: I.41, P.42, T.43, R.65
Ligand excluded by PLIPSO4.44: 3 residues within 4Å:- Chain B: R.335, A.336, S.337
Ligand excluded by PLIPSO4.45: 3 residues within 4Å:- Chain B: T.510, L.535, H.536
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Z. et al., Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA. Immunity (2016)
- Release Date
- 2016-11-02
- Peptides
- Toll-like receptor 7: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x RX8: 1-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol(Non-covalent)
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 28 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Z. et al., Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA. Immunity (2016)
- Release Date
- 2016-11-02
- Peptides
- Toll-like receptor 7: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B